English
简体中文
Total: £ 56.28
Published Date: 2025-09-18 | Pages: 76 | Tables: 76 | Pharma & Healthcare
The global T-Cell & NK-Cell Engaging Bispecific Antibodies market size was US$ 890 million in 2024 and is forecast to a readjusted size of US$ 9573 million by 2031 with a CAGR of 41.0% during the forecast period 2025-2031.
By 2025, the evolving U.S. tariff policy is poised to inject considerable uncertainty into the global economic landscape. This report delves into the latest U.S. tariff measures and the corresponding policy responses across the globe, evaluating their impacts on T-Cell & NK-Cell Engaging Bispecific Antibodies market competitiveness, regional economic performance, and supply chain configurations.
A Bispecific Antibodies is designed to bind two different targets or epitopes and can thereby exert two different functions. They are currently used to treat infectious, inflammatory, and malignant diseases.
Most cell-bridging bsAbs are designed for cancer treatment by linking immune cells to malignant cells. Through sequential binding, that is, by binding the cancer cell first owing to a higher affinity to tumor antigens, cell-bridging bsAbs can improve specificity and effectiveness with reduced non-specific side effects and lower dosage compared with mAbs.
bsAbs are designed to achieve different functions through single or multiple MoAs: bridging tumor cells and immune cells for redirected cytotoxicity, blocking two targets to inhibit tumor growth, promoting immune cell functions, or facilitating the formation of protein complexes.
In this report, we study the Bispecific Antibodies drugs based on T-Cell or NK-Cell.
Drivers of the T-Cell & NK-Cell Engaging Bispecific Antibodies Market
The T-Cell & NK-Cell Engaging Bispecific Antibodies market is driven by the growing prevalence of cancer and the rising demand for advanced immunotherapies. These innovative therapies harness the body’s immune system to target and destroy cancer cells with high precision, offering significant advantages over traditional treatments. Advancements in antibody engineering and the increasing adoption of combination therapies further fuel market growth. Additionally, substantial investments in research and development by pharmaceutical companies and supportive regulatory environments accelerate the development and commercialization of these promising therapeutics.
Challenges in the T-Cell & NK-Cell Engaging Bispecific Antibodies Market
Despite their potential, the market faces challenges such as high development costs and complex manufacturing processes. Producing bispecific antibodies involves intricate design and quality control measures, which can limit scalability and increase expenses. Moreover, the safety profile of these therapies, particularly in managing immune-related adverse events, remains a concern. Regulatory hurdles and the need for extensive clinical trials to demonstrate efficacy and safety also delay product approvals, posing a significant barrier to market entry for smaller companies and new players.
Global key players of T-Cell & NK-Cell engaging bispecific antibodies include Amgen and Immunocore. These two manufactures hold the total market share in the world. The key players are mainly located in Europe and North America. In terms of product, T-Cell engagers is the largest segment, with a share over 93%. And in terms of application, the largest application is solid tumors, with a share over 71%.
The global T-Cell & NK-Cell Engaging Bispecific Antibodies market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
Amgen
Immunocore
Johnson & Johnson
Roche
Pfizer
AbbVie
MacroGenics
Regeneron
By Type: (Dominant Segment vs High-Margin Innovation)
T-Cell Engagers
NK-Cell Engagers
By Application: (Core Demand Driver vs Emerging Opportunity)
Hematological Cancers
Solid Tumors
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Amgen in Europe)
- Emerging Product Trends: T-Cell Engagers adoption vs. NK-Cell Engagers premiumization
- Demand-Side Dynamics: Hematological Cancers growth in China vs. Solid Tumors potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
(Additional regions can be customized based on client needs.)
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of T-Cell & NK-Cell Engaging Bispecific Antibodies market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., NK-Cell Engagers in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Solid Tumors in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
This is not just another market study. By fusing global trend analysis with hyper-local operational intelligence, we deliver:
- Risk-Controlled Market Entry: Navigate regulatory complexities in focus markets (e.g., China’s policies).
- Product Portfolio Optimization: Align offerings with regional preferences (e.g., T-Cell Engagers dominance in Europe vs. NK-Cell Engagers demand in MEA).
- Competitor Counterstrategies: Decode player tactics in fragmented vs. consolidated markets.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Market Overview
1.1 T-Cell & NK-Cell Engaging Bispecific Antibodies Product Scope
1.2 T-Cell & NK-Cell Engaging Bispecific Antibodies by Type
1.2.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Type (2020 & 2024 & 2031)
1.2.2 T-Cell Engagers
1.2.3 NK-Cell Engagers
1.3 T-Cell & NK-Cell Engaging Bispecific Antibodies by Application
1.3.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Hematological Cancers
1.3.3 Solid Tumors
1.4 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Estimates and Forecasts (2020-2031)
1.4.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size in Value Growth Rate (2020-2031)
1.4.2 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share by Region (2020-2025)
2.2.2 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share by Region (2020-2025)
2.3 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size and Prospective (2020-2031)
2.4.2 Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Historic Market Review by Type (2020-2025)
3.1.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Type (2020-2025)
3.1.2 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Type (2020-2025)
3.1.3 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Price by Type (2020-2025)
3.2 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Forecast by Type (2026-2031)
3.2.2 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Forecast by Type (2026-2031)
3.2.3 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Price Forecast by Type (2026-2031)
3.3 Different Types T-Cell & NK-Cell Engaging Bispecific Antibodies Representative Players
4 Global Market Size by Application
4.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Historic Market Review by Application (2020-2025)
4.1.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Application (2020-2025)
4.1.2 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Application (2020-2025)
4.1.3 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Price by Application (2020-2025)
4.2 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Forecast by Application (2026-2031)
4.2.2 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Forecast by Application (2026-2031)
4.2.3 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in T-Cell & NK-Cell Engaging Bispecific Antibodies Application
5 Competition Landscape by Players
5.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Players (2020-2025)
5.2 Global Top T-Cell & NK-Cell Engaging Bispecific Antibodies Players by Revenue (2020-2025)
5.3 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in T-Cell & NK-Cell Engaging Bispecific Antibodies as of 2024)
5.4 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of T-Cell & NK-Cell Engaging Bispecific Antibodies, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of T-Cell & NK-Cell Engaging Bispecific Antibodies, Product Type & Application
5.7 Global Key Manufacturers of T-Cell & NK-Cell Engaging Bispecific Antibodies, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Company
6.1.1.1 North America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Company (2020-2025)
6.1.1.2 North America T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Company (2020-2025)
6.1.2 North America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Breakdown by Type (2020-2025)
6.1.3 North America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Breakdown by Application (2020-2025)
6.1.4 North America T-Cell & NK-Cell Engaging Bispecific Antibodies Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Company
6.2.1.1 Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Company (2020-2025)
6.2.1.2 Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Company (2020-2025)
6.2.2 Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Breakdown by Type (2020-2025)
6.2.3 Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Breakdown by Application (2020-2025)
6.2.4 Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Major Customer
6.2.5 Europe Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 Amgen
7.1.1 Amgen Company Information
7.1.2 Amgen Business Overview
7.1.3 Amgen T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, Revenue and Gross Margin (2020-2025)
7.1.4 Amgen T-Cell & NK-Cell Engaging Bispecific Antibodies Products Offered
7.1.5 Amgen Recent Development
7.2 Immunocore
7.2.1 Immunocore Company Information
7.2.2 Immunocore Business Overview
7.2.3 Immunocore T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Immunocore T-Cell & NK-Cell Engaging Bispecific Antibodies Products Offered
7.2.5 Immunocore Recent Development
7.3 Johnson & Johnson
7.3.1 Johnson & Johnson Company Information
7.3.2 Johnson & Johnson Business Overview
7.3.3 Johnson & Johnson T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Johnson & Johnson T-Cell & NK-Cell Engaging Bispecific Antibodies Products Offered
7.3.5 Johnson & Johnson Recent Development
7.4 Roche
7.4.1 Roche Company Information
7.4.2 Roche Business Overview
7.4.3 Roche T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, Revenue and Gross Margin (2020-2025)
7.4.4 Roche T-Cell & NK-Cell Engaging Bispecific Antibodies Products Offered
7.4.5 Roche Recent Development
7.5 Pfizer
7.5.1 Pfizer Company Information
7.5.2 Pfizer Business Overview
7.5.3 Pfizer T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Pfizer T-Cell & NK-Cell Engaging Bispecific Antibodies Products Offered
7.5.5 Pfizer Recent Development
7.6 AbbVie
7.6.1 AbbVie Company Information
7.6.2 AbbVie Business Overview
7.6.3 AbbVie T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, Revenue and Gross Margin (2020-2025)
7.6.4 AbbVie T-Cell & NK-Cell Engaging Bispecific Antibodies Products Offered
7.6.5 AbbVie Recent Development
7.7 MacroGenics
7.7.1 MacroGenics Company Information
7.7.2 MacroGenics Business Overview
7.7.3 MacroGenics T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, Revenue and Gross Margin (2020-2025)
7.7.4 MacroGenics T-Cell & NK-Cell Engaging Bispecific Antibodies Products Offered
7.7.5 MacroGenics Recent Development
7.8 Regeneron
7.8.1 Regeneron Company Information
7.8.2 Regeneron Business Overview
7.8.3 Regeneron T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, Revenue and Gross Margin (2020-2025)
7.8.4 Regeneron T-Cell & NK-Cell Engaging Bispecific Antibodies Products Offered
7.8.5 Regeneron Recent Development
8 T-Cell & NK-Cell Engaging Bispecific Antibodies Manufacturing Cost Analysis
8.1 T-Cell & NK-Cell Engaging Bispecific Antibodies Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of T-Cell & NK-Cell Engaging Bispecific Antibodies
8.4 T-Cell & NK-Cell Engaging Bispecific Antibodies Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 T-Cell & NK-Cell Engaging Bispecific Antibodies Distributors List
9.3 T-Cell & NK-Cell Engaging Bispecific Antibodies Customers
10 T-Cell & NK-Cell Engaging Bispecific Antibodies Market Dynamics
10.1 T-Cell & NK-Cell Engaging Bispecific Antibodies Industry Trends
10.2 T-Cell & NK-Cell Engaging Bispecific Antibodies Market Drivers
10.3 T-Cell & NK-Cell Engaging Bispecific Antibodies Market Challenges
10.4 T-Cell & NK-Cell Engaging Bispecific Antibodies Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
List of Tables
Table 1. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)
Table 2. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)
Table 3. Global Market T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (K Units) by Region (2020-2025)
Table 5. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share by Region (2020-2025)
Table 6. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue (US$ Million) Market Share by Region (2020-2025)
Table 7. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Share by Region (2020-2025)
Table 8. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (K Units) Forecast by Region (2026-2031)
Table 9. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share Forecast by Region (2026-2031)
Table 10. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue (US$ Million) Forecast by Region (2026-2031)
Table 11. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Share Forecast by Region (2026-2031)
Table 12. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Type (K Units) & (2020-2025)
Table 13. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Share by Type (2020-2025)
Table 14. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Type (US$ Million) & (2020-2025)
Table 15. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Price by Type (US$/Unit) & (2020-2025)
Table 16. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Type (K Units) & (2026-2031)
Table 17. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Type (US$ Million) & (2026-2031)
Table 18. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Price by Type (US$/Unit) & (2026-2031)
Table 19. Representative Players of Each Type
Table 20. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Application (K Units) & (2020-2025)
Table 21. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Share by Application (2020-2025)
Table 22. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Application (US$ Million) & (2020-2025)
Table 23. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Price by Application (US$/Unit) & (2020-2025)
Table 24. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Application (K Units) & (2026-2031)
Table 25. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share by Application (US$ Million) & (2026-2031)
Table 26. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Price by Application (US$/Unit) & (2026-2031)
Table 27. New Sources of Growth in T-Cell & NK-Cell Engaging Bispecific Antibodies Application
Table 28. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Company (K Units) & (2020-2025)
Table 29. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Share by Company (2020-2025)
Table 30. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Company (US$ Million) & (2020-2025)
Table 31. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Share by Company (2020-2025)
Table 32. Global T-Cell & NK-Cell Engaging Bispecific Antibodies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in T-Cell & NK-Cell Engaging Bispecific Antibodies as of 2024)
Table 33. Global Market T-Cell & NK-Cell Engaging Bispecific Antibodies Average Price by Company (US$/Unit) & (2020-2025)
Table 34. Global Key Manufacturers of T-Cell & NK-Cell Engaging Bispecific Antibodies, Manufacturing Sites & Headquarters
Table 35. Global Key Manufacturers of T-Cell & NK-Cell Engaging Bispecific Antibodies, Product Type & Application
Table 36. Global Key Manufacturers of T-Cell & NK-Cell Engaging Bispecific Antibodies, Date of Enter into This Industry
Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 38. North America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Company (2020-2025) & (K Units)
Table 39. North America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share by Company (2020-2025)
Table 40. North America T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Company (2020-2025) & (US$ Million)
Table 41. North America T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share by Company (2020-2025)
Table 42. North America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Type (2020-2025) & (K Units)
Table 43. North America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share by Type (2020-2025)
Table 44. North America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Application (2020-2025) & (K Units)
Table 45. North America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share by Application (2020-2025)
Table 46. Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Company (2020-2025) & (K Units)
Table 47. Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share by Company (2020-2025)
Table 48. Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Company (2020-2025) & (US$ Million)
Table 49. Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share by Company (2020-2025)
Table 50. Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Type (2020-2025) & (K Units)
Table 51. Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share by Type (2020-2025)
Table 52. Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Application (2020-2025) & (K Units)
Table 53. Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share by Application (2020-2025)
Table 54. Amgen Company Information
Table 55. Amgen Description and Business Overview
Table 56. Amgen T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 57. Amgen T-Cell & NK-Cell Engaging Bispecific Antibodies Product
Table 58. Amgen Recent Development
Table 59. Immunocore Company Information
Table 60. Immunocore Description and Business Overview
Table 61. Immunocore T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 62. Immunocore T-Cell & NK-Cell Engaging Bispecific Antibodies Product
Table 63. Immunocore Recent Development
Table 64. Johnson & Johnson Company Information
Table 65. Johnson & Johnson Description and Business Overview
Table 66. Johnson & Johnson T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 67. Johnson & Johnson T-Cell & NK-Cell Engaging Bispecific Antibodies Product
Table 68. Johnson & Johnson Recent Development
Table 69. Roche Company Information
Table 70. Roche Description and Business Overview
Table 71. Roche T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. Roche T-Cell & NK-Cell Engaging Bispecific Antibodies Product
Table 73. Roche Recent Development
Table 74. Pfizer Company Information
Table 75. Pfizer Description and Business Overview
Table 76. Pfizer T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 77. Pfizer T-Cell & NK-Cell Engaging Bispecific Antibodies Product
Table 78. Pfizer Recent Development
Table 79. AbbVie Company Information
Table 80. AbbVie Description and Business Overview
Table 81. AbbVie T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 82. AbbVie T-Cell & NK-Cell Engaging Bispecific Antibodies Product
Table 83. AbbVie Recent Development
Table 84. MacroGenics Company Information
Table 85. MacroGenics Description and Business Overview
Table 86. MacroGenics T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 87. MacroGenics T-Cell & NK-Cell Engaging Bispecific Antibodies Product
Table 88. MacroGenics Recent Development
Table 89. Regeneron Company Information
Table 90. Regeneron Description and Business Overview
Table 91. Regeneron T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 92. Regeneron T-Cell & NK-Cell Engaging Bispecific Antibodies Product
Table 93. Regeneron Recent Development
Table 94. Production Base and Market Concentration Rate of Raw Material
Table 95. Key Suppliers of Raw Materials
Table 96. T-Cell & NK-Cell Engaging Bispecific Antibodies Distributors List
Table 97. T-Cell & NK-Cell Engaging Bispecific Antibodies Customers List
Table 98. T-Cell & NK-Cell Engaging Bispecific Antibodies Market Trends
Table 99. T-Cell & NK-Cell Engaging Bispecific Antibodies Market Drivers
Table 100. T-Cell & NK-Cell Engaging Bispecific Antibodies Market Challenges
Table 101. T-Cell & NK-Cell Engaging Bispecific Antibodies Market Restraints
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
List of Figures
Figure 1. T-Cell & NK-Cell Engaging Bispecific Antibodies Product Picture
Figure 2. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (US$ Million) by Type (2020 & 2024 & 2031)
Figure 3. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share by Type in 2024 & 2031
Figure 4. T-Cell Engagers Product Picture
Figure 5. NK-Cell Engagers Product Picture
Figure 6. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (US$ Million) by Application (2020 & 2024 & 2031)
Figure 7. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share by Application in 2024 & 2031
Figure 8. Hematological Cancers Examples
Figure 9. Solid Tumors Examples
Figure 10. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Growth Rate (2020-2031) & (US$ Million)
Figure 12. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (K Units) Growth Rate (2020-2031)
Figure 13. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Price Trends Growth Rate (2020-2031) & (US$/Unit)
Figure 14. T-Cell & NK-Cell Engaging Bispecific Antibodies Report Years Considered
Figure 15. Global Market T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Figure 16. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share by Region: 2020 VS 2024
Figure 17. North America T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue (US$ Million) Growth Rate (2020-2031)
Figure 18. North America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (K Units) Growth Rate (2020-2031)
Figure 19. Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue (US$ Million) Growth Rate (2020-2031)
Figure 20. Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (K Units) Growth Rate (2020-2031)
Figure 21. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Share by Type (2020-2025)
Figure 22. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Share by Type (2026-2031)
Figure 23. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Share by Type (2026-2031)
Figure 24. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Share by Application (2020-2025)
Figure 25. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Growth Rate by Application in 2020 & 2024
Figure 26. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Share by Application (2026-2031)
Figure 27. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Share by Application (2026-2031)
Figure 28. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Share by Company (2024)
Figure 29. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Share by Company (2024)
Figure 30. Global 5 Largest T-Cell & NK-Cell Engaging Bispecific Antibodies Players Market Share by Revenue in T-Cell & NK-Cell Engaging Bispecific Antibodies: 2020 & 2024
Figure 31. T-Cell & NK-Cell Engaging Bispecific Antibodies Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 32. Manufacturing Cost Structure of T-Cell & NK-Cell Engaging Bispecific Antibodies
Figure 33. Manufacturing Process Analysis of T-Cell & NK-Cell Engaging Bispecific Antibodies
Figure 34. T-Cell & NK-Cell Engaging Bispecific Antibodies Industrial Chain
Figure 35. Channels of Distribution (Direct Vs Distribution)
Figure 36. Distributors Profiles
Figure 37. Bottom-up and Top-down Approaches for This Report
Figure 38. Data Triangulation
Figure 39. Key Executives Interviewed
